Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Therapy for aplastic anemia

    ... registry, including cord blood. He is red cell- and platelet transfusion -dependent. He has been recommended therapy with ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. The long term risk of myelodysplastic syndromes among anemia patients: A population-based study.

    ... white blood cell count of less than 3500/mm(3), and platelet count of less than 100×10(9)/L were associated with a ...

    Research Article last updated 07/20/2018 - 5:14pm.

  3. Current and future management options for myelodysplastic syndromes.

    ... supportive care measures consisting of blood and platelet transfusions, haematopoietic growth factors and antimicrobials ...

    Research Article last updated 07/20/2018 - 5:14pm.

  4. Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: A report on 62 cases.

    ... del 20q and patients without del 20q were lower platelet count (mean 144 vs. 196 G/l, p=0.005), lower marrow blast count ...

    Research Article last updated 07/20/2018 - 5:14pm.

  5. Loss of expression of neutrophil proteinase-3: a contributory factor in thrombotic risk in paroxysmal nocturnal hemoglobinuria.

    ... Finally, we studied the effects of proteinase 3 on platelet activation using an in vitro aggregometry assay and flow ...

    Research Article last updated 07/20/2018 - 5:14pm.

  6. Comparison of Outcomes after Transplantation of G-CSF-Stimulated Bone Marrow Grafts versus Bone Marrow or Peripheral Blood Grafts from HLA-Matched Sibling Donors for Patients with Severe Aplastic Anemia.

    ... in 1997 to 2003. Rates of neutrophil and platelet recovery were not different among the 3 treatment groups. Grade ...

    Research Article last updated 07/20/2018 - 5:14pm.

  7. Comparison between Matched Related and Alternative Donors of Allogeneic Hematopoietic Stem Cells Transplanted into Adult Patients with Acquired Aplastic Anemia: Multivariate and Propensity Score-Matched Analysis.

    ... absence of acute graft-versus-host disease (aGVHD), and platelet engraftment at ≤21 days, were independent predictors of longer ...

    Research Article last updated 07/20/2018 - 5:14pm.

  8. Symptoms

    ... Low Platelet Counts A low platelet count is called thrombocytopenia . If you have a low ...

    Topic section last updated 07/24/2018 - 9:27am.

  9. Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia

    ... time of 16 days (range 9-25 days). The median time of platelet engraftment was 22 days (range 9-95 days) in 16 patients. The ...

    Research Article last updated 07/20/2018 - 5:15pm.

  10. HLA-Matched Sibling Transplantation for Severe Aplastic Anemia: Impact of HLA DR15 Antigen Status on Engraftment, Graft-versus-Host Disease, and Overall Survival.

    ... = .01). However, neutrophil recovery at day -28, platelet recovery at day -100, acute GVHD, chronic GVHD, and overall ...

    Research Article last updated 07/20/2018 - 5:14pm.